Author

F. Gustafsson

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Six-minute walk distance and long-term outcomes in contemporary left ventricular assist device recipients: the ELEVATE Registry.

OBJECTIVES This study aimed to assess the prognostic value of Six-minute Walk Distance (6MWD) in stable HeartMate 3 (HM3) recipients. METHODS Data from patients with available 6MWD at six months post-implant were obtained from the prospective, multicenter ELEVATE registry. Overall survival and adverse event rates wer...

W. H. Nielsen, F. Gustafsson, S. Shaw et al. · Interdisciplinary cardiovasc... · 0 citations

Aug 2026

Dapagliflozin in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: The DAPAH randomized controlled trial.

BACKGROUND SGLT2 inhibitors (SGLT2i) reduce mortality in left heart failure. In pulmonary arterial hypertension (PAH), preclinical data suggest SGLT2i improve right ventricular function through metabolic modulation and inhibition of vascular remodeling via smooth muscle cell pathways. The DAPAH trial evaluated whether...

M. Ersbøll, J. Kjærgaard, K. Waidtløw et al. · The Journal of Heart and Lun... · 1 citation

Open access Aug 2026

Ambulatory low cardiac output state in heart failure: characteristics and outcomes

Abstract Introduction Ambulatory low cardiac output state (LCOS) is a known but poorly described heart failure (HF) phenotype. We aimed to investigate the prevalence, clinical markers, and prognostic importance of ambulatory LCOS. Methods Consecutive ambulatory patients with HF and reduced left ventricular ejection fra...

B. Hansen, T. Deis, Cecilie Müller Ralsted et al. · ESC Heart Failure · 0 citations